BPA in Food Packaging Right to Know Act

Bottled water labeling and quality; regulation of Bisphenol A in food and beverage containers, including S. 821 "BPA in Food Packaging Right to Know Act"; FDA vending machine rules; access to potable water in schools during emergencies, including H.R. 5003 "Improving Child Nutrition and Education Act of 2016"

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Bottled water quality; regulation of Bisphenol A in food and beverage containers, including S. 821 "BPA in Food Packaging Right to Know Act"

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Legislation in the 114th Congress: S. 1014, Personal Care Products Safety Act The Breast Cancer Fund continues to meet with staff from Senator Feinsteins office and other HELP committee offices to encourage legislative action on the issue of safety of Personal Care Products. The Breast Cancer Fund supports action that would effectively regulate Personal Care Products and Cosmetics to protect the health of consumers, workers, and communities. The Breast Cancer Fund also continues to meet with staff from House offices to encourage introduction of legislation in the House to reform the FDAs regulation of cosmetics and personal care product ingredients to prevent the use of chemicals found to have negative health and environmental impacts. S. 725, Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. S. 821, BPA in Food Packaging Right to Know Act The Breast Cancer Fund continues to meet with staff from Senate offices to encourage legislative action on the issue of bisphenol-A, which has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund supports action that would ban bisphenol-A from the linings of canned food, foods marketed to children, and food storage containers. S. 3412, Ban Poisonous Additives Act of 2016 The Breast Cancer Fund supports this legislation that would ban bisphenol-A in food containers and prevent manufacturers from replacing bisphenol-A in food containers with unsafe alternatives because bisphenol-A has been linked to increased rates of cancer, as well as other significant health problems. H.R. 6269, Ban Poisonous Additives Act of 2016 The Breast Cancer Fund supports this legislation that would ban bisphenol-A in food containers and prevent manufacturers from replacing bisphenol-A in food containers with unsafe alternatives because bisphenol-A has been linked to increased rates of cancer, as well as other significant health problems. H.R. 5205, Cleaning Product Right to Know Act of 2016 The Breast Cancer Fund supports this bill that would require cleaning products to be labeled with all the ingredients contained therein. The Breast Cancer Fund has been meeting with House offices to urge Members to cosponsor the bill, and also with Senate offices to urge Senators to take up the issue in the Senate. HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Fund contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) The Breast Cancer Fund contacted Senate offices about preserving the current Design for the Environment program in the EPA. FUTURE LEGISLATIVE PROPOSALS: The Breast Cancer Fund visits Senate offices to support an amendment to the Senate NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Fund supports actions to ensure appropriate definition and regulation of chemicals Generally Recognized as Safe (GRAS). REGULATION AND LEGISLATIVE INTENT: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Fund has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. P.L. 110-314 - The Consumer Product Safety Commission Improvement Act The Breast Cancer Fund lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation. P.L. 114-182 - The Frank R. Lautenberg Chemical Safety for the 21st Century Act The Breast Cancer Fund is working to support and encourage strong, health-protective implementation of the recently- enacted reform of the Toxic Substances Control Act (TSCA).

Bottled water quality; regulation of Bisphenol A in food and beverage containers, including S. 821 "BPA in Food Packaging Right to Know Act"

Client expense: $140,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

Bottled water labeling and quality; regulation of Bisphenol A in food and beverage containers, including S. 821 "BPA in Food Packaging Right to Know Act"; FDA vending machine rules; access to potable water in schools during emergencies, including H.R. 5003 "Improving Child Nutrition and Education Act of 2016"

Client expense: $140,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

H.R. 185, Regulatory Accountability Act of 2015; H.R. 527; Small Business Regulatory Flexibility Improvements Act of 2015; H.R. 1029, EPA Science Advisory Board Reform Act of 2015; H.R. 1030, Secret Science Reform Act of 2015; H.R. 1321, Microbead-Free Waters Act of 2015; H.R. 2576; TSCA Modernization Act of 2015; H.R. 2577, Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2016; H.R. 2822, Department of the Interior, Environment, and Related Agencies Appropriations Act, 2016; H.R. 2995, Financial Services and General Government Appropriations Act, 2016; H.R. 3977, Trash Reduction Act of 2015; H.R. 4923, American Manufacturing Competitiveness Act of 2016; H.R. 5538, Department of the Interior, Environment, and Related Agencies Appropriations Act of 2017; S. 543, EPA Science Advisory Board Reform Act of 2015; S. 544, Secret Science Reform Act of 2015; S. 697, Frank R. Lautenberg Chemical Safety for the 21st Century Act; S. 700, READ Act; S. 725, Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act; S. 821, BPA in Food Packaging Right to Know Act; S. 1014, Personal Care Products Safety Act; S. 1447, Sustainable Chemistry Research and Development Act of 2015; S. 2794, American Manufacturing Competitiveness Act of 2016; S. 3068, Department of the Interior, Environment, and Related Agencies Appropriations Act of 2017; FY 2016 Appropriations of Department of Interior; FY 2016 Appropriations of Environmental Protection Agency; FY 2016 Appropriations Financial Services and General Government (Green Building Policies, Phthalates, CHAP and CPSC); FY 2016 Appropriations of Transportation, Housing and Urban Development, and Related Agencies; Good Science; FY 2017 Appropriations of Commerce, Justice, Science and Related Agencies; FY 2017 Appropriations of Department of Interior; FY 2017 Appropriations of Financial Services and General Government; FY 2017 Appropriations of Department of Labor, Health and Human Services; A Bill to Provide for the Implementation of a Sustainable Chemistry Program, and for other Purposes; Alternative Fuel Tax Assessment; Bisphenol A; Building and Construction water infrastructure; Chemical Assessment; Chemical Safety Board; Chemistry Caucus (Creation and Recruitment); Chlorinated Paraffins; CPSC; CPSC Phthalates CHAP; Design for the Environment; Energy Recovery; Flame Retardants; Fluorotechnology; Formaldehyde; Green Building Standards; Hexavalent Chromium; Integrated Risk Information System; Labeling, including GMOs; Microbeads; Microplastics; Nanotechnology; OSHA Letters of Interpretation (Chemical Concentrations, Process Safety, RAGAGEP); OSHA Crystalline Silica Rule; Permitting Reform; Phthalates; Promoting New Manufacturing Act; Rare Earths; Risk Assessment Improvements; Report on Carcinogens; Science Advisory Board; SNUR; Styrene; T-TIP, MTB and Trade Promotion Authority; Titanium Dioxide; Toxic Substances Control Act (TSCA)(Including Confidential Business Information)

Bottled water quality; regulation of Bisphenol A in food and beverage containers, including S. 821 "BPA in Food Packaging Right to Know Act"

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Bottled water labeling and quality; regulation of Bisphenol A in food and beverage containers, including S. 821 "BPA in Food Packaging Right to Know Act"; FDA vending machine rules; access to potable water in schools during emergencies, including H.R. 5003 "Improving Child Nutrition and Education Act of 2016"

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

LEGISLATION IN THE 114TH CONGRESS​ S.1014, Personal Care Products Safety Act The Breast Cancer Fund continues to meet with staff from Senator Feinsteins office and other HELP committee offices to encourage legislative action on the issue of safety of Personal Care Products. The Breast Cancer Fund supports action that would remove toxins and regulate Personal Care Products and Cosmetics. H.R.2576, TSCA Modernization Act of 2015 The Breast Cancer Fund supports this bill and has been meeting with House and Senate offices to persuade members to take up the bill in the Senate. S. 697, Frank R. Lautenberg Chemical Safety for the 21st Century Act The Breast Cancer Fund opposes this legislation without amendments, as it would do little to strengthen the current TSCA law, but continues to work with members of the Senate Committee on Environment and Public Works to improve and strengthen the bill. S. 725, Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. S. 821, BPA in Food Packaging Right to Know Act The Breast Cancer Fund continues to meet with staff from Senate offices to encourage legislative action on the issue of bisphenol-A, which has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund support action that would ban bisphenol-A from the linings of canned food, foods marketed to children, and food storage containers. HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Fund contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) The Breast Cancer Fund contacted Senate offices about preserving the current Design for the Environment program in the EPA. FUTURE LEGISLATIVE PROPOSALS: The Breast Cancer Fund visits Senate offices to support an amendment to the Senate NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). The Breast Cancer Fund supports this legislation to reform the FDAs regulation of cosmetic and personal care product ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Fund continues to talk with staff from Senate offices about the introduction of legislation in the Senate to reform the FDAs regulation of cosmetics and personal care product ingredients to prevent the use of chemicals found to have negative health and environmental impacts. REGULATION AND LEGISLATIVE INTENT: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Fund has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. P.L. 110-314 - The Consumer Product Safety Commission Improvement Act The Breast Cancer Fund lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation. Lobbying: U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Consumer Product Safety Commission (CPSC), National Institutes of Health (NIH), Environmental Protection Agency (EPA), Executive Office of the President (EOP), Office of Management & Budget (OMB), Health & Human Services - Department of (HHS), Office of Science & Technology Policy (OSTP), Health & Human Services - Dept of (HHS), Food & Drug Administration (FDA)

H.R. 185, Regulatory Accountability Act of 2015; H.R. 527; Small Business Regulatory Flexibility Improvements Act of 2015; H.R. 1029, EPA Science Advisory Board Reform Act of 2015; H.R. 1030, Secret Science Reform Act of 2015; H.R. 1321, Microbead-Free Waters Act of 2015; H.R. 2576; TSCA Modernization Act of 2015; H.R. 2577, Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2016; H.R. 2822, Department of the Interior, Environment, and Related Agencies Appropriations Act, 2016; H.R. 2995, Financial Services and General Government Appropriations Act, 2016; H.R. 3977, Trash Reduction Act of 2015; H.R. 4923, American Manufacturing Competitiveness Act of 2016; H.R. 5538, Department of the Interior, Environment, and Related Agencies Appropriations Act of 2017; S. 543, EPA Science Advisory Board Reform Act of 2015; S. 544, Secret Science Reform Act of 2015; S. 697, Frank R. Lautenberg Chemical Safety for the 21st Century Act; S. 700, READ Act; S. 725, Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act; S. 821, BPA in Food Packaging Right to Know Act; S. 1014, Personal Care Products Safety Act; S. 1447, Sustainable Chemistry Research and Development Act of 2015; S. 2794, American Manufacturing Competitiveness Act of 2016; S. 3068, Department of the Interior, Environment, and Related Agencies Appropriations Act of 2017; FY 2016 Appropriations of Department of Interior; FY 2016 Appropriations of Environmental Protection Agency; FY 2016 Appropriations Financial Services and General Government (Green Building Policies, Phthalates, CHAP and CPSC); FY 2016 Appropriations of Transportation, Housing and Urban Development, and Related Agencies; Good Science; FY 2017 Appropriations of Commerce, Justice, Science and Related Agencies; FY 2017 Appropriations of Department of Interior; FY 2017 Appropriations of Financial Services and General Government; FY 2017 Appropriations of Department of Labor, Health and Human Services; A Bill to Provide for the Implementation of a Sustainable Chemistry Program, and for other Purposes; Alternative Fuel Tax Assessment; Bisphenol A; Building and Construction water infrastructure; Chemical Assessment; Chemical Safety Board; Chemistry Caucus (Creation and Recruitment); Chlorinated Paraffins; CPSC; CPSC Phthalates CHAP; Design for the Environment; Energy Recovery; Flame Retardants; Fluorotechnology; Formaldehyde; Green Building Standards; Hexavalent Chromium; Integrated Risk Information System; Microbeads; Microplastics; Nanotechnology; OSHA Letters of Interpretation (Chemical Concentrations, Process Safety, RAGAGEP); OSHA Crystalline Silica Rule; Permitting Reform; Phthalates; Promoting New Manufacturing Act; Rare Earths; Risk Assessment Improvements; Report on Carcinogens; Science Advisory Board; SNUR; Styrene; T-TIP, MTB and Trade Promotion Authority; Toxic Substances Control Act (TSCA)(Including Confidential Business Information)

Bottled water quality; regulation of Bisphenol A in food and beverage containers, including S. 821 "BPA in Food Packaging Right to Know Act"

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Bottled water labeling and quality; regulation of Bisphenol A in food and beverage containers, including S. 821 "BPA in Food Packaging Right to Know Act"; FDA vending machine rules; access to potable water in schools during emergencies, including H.R. 5003 "Improving Child Nutrition and Education Act of 2016"

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Bottled water labeling and quality; regulation of Bisphenol A in food and beverage containers, including S. 821 "BPA in Food Packaging Right to Know Act"; FDA vending machine rules; access to potable water in schools during emergencies, including H.R. 5003 "Improving Child Nutrition and Education Act of 2016"

Client expense: $170,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

Bottled water quality; regulation of Bisphenol A in food and beverage containers, including S. 821 "BPA in Food Packaging Right to Know Act"

Client expense: $170,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

LEGISLATION IN THE 114TH CONGRESS​ S.1014, Personal Care Products Safety Act The Breast Cancer Fund continues to meet with staff from Senator Feinsteins office and other HELP committee offices to encourage legislative action on the issue of safety of Personal Care Products. The Breast Cancer Fund supports action that would remove toxins and regulate Personal Care Products and Cosmetics. H.R.2576, TSCA Modernization Act of 2015 The Breast Cancer Fund supports this bill and has been meeting with House and Senate offices to persuade members to take up the bill in the Senate. S. 697, Frank R. Lautenberg Chemical Safety for the 21st Century Act The Breast Cancer Fund opposes this legislation without amendments, as it would do little to strengthen the current TSCA law, but continues to work with members of the Senate Committee on Environment and Public Works to improve and strengthen the bill. S. 725, Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. S. 821, BPA in Food Packaging Right to Know Act The Breast Cancer Fund continues to meet with staff from Senate offices to encourage legislative action on the issue of bisphenol-A, which has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund support action that would ban bisphenol-A from the linings of canned food, foods marketed to children, and food storage containers. HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Fund contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) The Breast Cancer Fund contacted Senate offices about preserving the current Design for the Environment program in the EPA. FUTURE LEGISLATIVE PROPOSALS: The Breast Cancer Fund visits Senate offices to support an amendment to the Senate NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). The Breast Cancer Fund supports this legislation to reform the FDAs regulation of cosmetic and personal care product ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Fund continues to talk with staff from Senate offices about the introduction of legislation in the Senate to reform the FDAs regulation of cosmetics and personal care product ingredients to prevent the use of chemicals found to have negative health and environmental impacts. REGULATION AND LEGISLATIVE INTENT: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Fund has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. P.L. 110-314 - The Consumer Product Safety Commission Improvement Act The Breast Cancer Fund lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation. Lobbying: U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Consumer Product Safety Commission (CPSC), National Institutes of Health (NIH), Environmental Protection Agency (EPA), Executive Office of the President (EOP), Office of Management & Budget (OMB), Health & Human Services - Department of (HHS), Office of Science & Technology Policy (OSTP), Health & Human Services - Dept of (HHS), Food & Drug Administration (FDA)

H.R. 185, Regulatory Accountability Act of 2015; H.R. 527; Small Business Regulatory Flexibility Improvements Act of 2015; H.R. 1029, EPA Science Advisory Board Reform Act of 2015; H.R. 1030, Secret Science Reform Act of 2015; H.R. 1321, Microbead-Free Waters Act of 2015; H.R. 2576; TSCA Modernization Act of 2015; H.R. 2577, Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2016; H.R. 2822, Department of the Interior, Environment, and Related Agencies Appropriations Act, 2016; H.R. 2995, Financial Services and General Government Appropriations Act, 2016; H.R. 3977, Trash Reduction Act of 2015; S. 543, EPA Science Advisory Board Reform Act of 2015; S. 544, Secret Science Reform Act of 2015; S. 697, Frank R. Lautenberg Chemical Safety for the 21st Century Act; S. 700, READ Act; S. 725, Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act; S. 821, BPA in Food Packaging Right to Know Act; S. 1014, Personal Care Products Safety Act; S. 1447, Sustainable Chemistry Research and Development Act of 2015; FY 2016 Appropriations of Department of Interior; FY 2016 Appropriations of Environmental Protection Agency; FY 2016 Appropriations Financial Services and General Government (Green Building Policies, Phthalates, CHAP and CPSC); FY 2016 Appropriations of Transportation, Housing and Urban Development, and Related Agencies; Good Science; FY 2017 Appropriations of Commerce, Justice, Science and Related Agencies; FY 2017 Appropriations of Department of Interior; FY 2017 Appropriations of Financial Services and General Government; FY 2017 Appropriations of Department of Labor, Health and Human Services; A Bill to Provide for the Implementation of a Sustainable Chemistry Program, and for other Purposes; Alternative Fuel Tax Assessment; Bisphenol A; Chemical Assessment; Chemical Safety Board; Chemistry Caucus (Creation and Recruitment); Chlorinated Paraffins; CPSC; CPSC Phthalates CHAP; Design for the Environment; Energy Recovery; Flame Retardants; Fluorotechnology; Formaldehyde; Green Building Standards; Hexavalent Chromium; Integrated Risk Information System; Microbeads; Microplastics; Nanotechnology; OSHA Letters of Interpretation (Chemical Concentrations, Process Safety, RAGAGEP); OSHA Crystalline Silica Rule; Permitting Reform; Phthalates; Promoting New Manufacturing Act; Rare Earths; Risk Assessment Improvements; Report on Carcinogens; Science Advisory Board; SNUR; Styrene; T-TIP, MTB and Trade Promotion Authority; Toxic Substances Control Act (TSCA)(Including Confidential Business Information)

Bottled water labeling and quality; regulation of Bisphenol A in food and beverage containers, S. 821 "BPA in Food Packaging Right to Know Act"

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Bottled water quality; regulation of Bisphenol A in food and beverage containers, S. 821 "BPA in Food Packaging Right to Know Act"

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Bottled water labeling and quality; regulation of Bisphenol A in food and beverage containers, S. 821; FDA vending machine rules

Client expense: $140,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

Bottled water quality; regulation of Bisphenol A in food and beverage containers, S. 821

Client expense: $140,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

LEGISLATION IN THE 114TH CONGRESS​ S.1014, Personal Care Products Safety Act The Breast Cancer Fund continues to meet with staff from Senator Feinsteins office and other HELP committee offices to encourage legislative action on the issue of safety of Personal Care Products. The Breast Cancer Fund supports action that would remove toxins and regulate Personal Care Products and Cosmetics. H.R.2576, TSCA Modernization Act of 2015 The Breast Cancer Fund supports this bill and has been meeting with House and Senate offices to persuade members to take up the bill in the Senate. S. 697, Frank R. Lautenberg Chemical Safety for the 21st Century Act The Breast Cancer Fund opposes this legislation without amendments, as it would do little to strengthen the current TSCA law, but continues to work with members of the Senate Committee on Environment and Public Works to improve and strengthen the bill. S. 725, Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. S. 821, BPA in Food Packaging Right to Know Act The Breast Cancer Fund continues to meet with staff from Senate offices to encourage legislative action on the issue of bisphenol-A, which has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund support action that would ban bisphenol-A from the linings of canned food, foods marketed to children, and food storage containers. H.R.1735, National Defense Authorization Act for FY2016 (NDAA) The Breast Cancer Fund supports an amendment to NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Fund contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) The Breast Cancer Fund contacted Senate offices about preserving the current Design for the Environment program in the EPA. FUTURE LEGISLATIVE PROPOSALS: The Breast Cancer Fund visits Senate offices to support an amendment to the Senate NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). The Breast Cancer Fund supports this legislation to reform the FDAs regulation of cosmetic and personal care product ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Fund continues to talk with staff from Senate offices about the introduction of legislation in the Senate to reform the FDAs regulation of cosmetics and personal care product ingredients to prevent the use of chemicals found to have negative health and environmental impacts. REGULATION AND LEGISLATIVE INTENT: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Fund has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. P.L. 110-314 - The Consumer Product Safety Commission Improvement Act The Breast Cancer Fund lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation. Lobbying: U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Consumer Product Safety Commission (CPSC), National Institutes of Health (NIH), Environmental Protection Agency (EPA), Executive Office of the President (EOP), Office of Management & Budget (OMB), Health & Human Services - Department of (HHS), Office of Science & Technology Policy (OSTP), Health & Human Services - Dept of (HHS), Food & Drug Administration (FDA)

H.R. 185, Regulatory Accountability Act of 2015; H.R. 527; Small Business Regulatory Flexibility Improvements Act of 2015; H.R. 1029, EPA Science Advisory Board Reform Act of 2015; H.R. 1030, Secret Science Reform Act of 2015; H.R. 1321, Microbead-Free Waters Act of 2015; H.R. 2576; TSCA Modernization Act of 2015; H.R. 2577, Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2016; H.R. 2822, Department of the Interior, Environment, and Related Agencies Appropriations Act, 2016; H.R. 2995, Financial Services and General Government Appropriations Act, 2016; H.R. 3977, Trash Reduction Act of 2015; S. 543, EPA Science Advisory Board Reform Act of 2015; S. 544, Secret Science Reform Act of 2015; S. 697, Frank R. Lautenberg Chemical Safety for the 21st Century Act; S. 700, READ Act; S. 725, Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act; S. 821, BPA in Food Packaging Right to Know Act; S. 1014, Personal Care Products Safety Act; S. 1447, Sustainable Chemistry Research and Development Act of 2015; FY 2016 Appropriations of Department of Interior; FY 2016 Appropriations of Environmental Protection Agency; FY 2016 Appropriations Financial Services and General Government (Green Building Policies, Phthalates, CHAP and CPSC); FY 2016 Appropriations of Transportation, Housing and Urban Development, and Related Agencies; Good Science; A Bill to Provide for the Implementation of a Sustainable Chemistry Program, and for other Purposes; Alternative Fuel Tax Assessment; Bisphenol A; Chemical Assessment; Chemical Safety Board; Chemistry Caucus (Creation and Recruitment); Chlorinated Paraffins; CPSC; CPSC Phthalates CHAP; Design for the Environment; Energy Recovery; Flame Retardants; Fluorotechnology; Formaldehyde; Green Building Standards; Hexavalent Chromium; Integrated Risk Information System; Microbeads; Microplastics; Nanotechnology; OSHA Letters of Interpretation (Chemical Concentrations, Process Safety, RAGAGEP); OSHA Silica Rule; Permitting Reform; Phthalates; Promoting New Manufacturing Act; Rare Earths; Risk Assessment Improvements; Report on Carcinogens; Science Advisory Board; SNUR; Styrene; T-TIP, MTB and Trade Promotion Authority; Toxic Substances Control Act (TSCA)(Including Confidential Business Information)

Bottled water labeling and quality; regulation of Bisphenol A in food and beverage containers, S. 821 "BPA in Food Packaging Right to Know Act"; FDA vending machine rules

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Bottled water quality; regulation of Bisphenol A in food and beverage containers, S. 821 "BPA in Food Packaging Right to Know Act"

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Bottled water labeling and quality; regulation of Bisphenol A in food and beverage containers, S. 821; FDA vending machine rules

Client expense: $100,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

Bottled water quality; regulation of Bisphenol A in food and beverage containers, S. 821

Client expense: $100,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

LEGISLATION IN THE 114TH CONGRESS​ S.1014, Personal Care Products Safety Act The Breast Cancer Fund continues to meet with staff from Senator Feinsteins office and other HELP committee offices to encourage legislative action on the issue of safety of Personal Care Products. The Breast Cancer Fund supports action that would remove toxins and regulate Personal Care Products and Cosmetics. H.R.2576, TSCA Modernization Act of 2015 The Breast Cancer Fund supports this bill and has been meeting with House and Senate offices to persuade members to take up the bill in the Senate. S. 697, Frank R. Lautenberg Chemical Safety for the 21st Century Act The Breast Cancer Fund opposes this legislation without amendments, as it would do little to strengthen the current TSCA law, but continues to work with members of the Senate Committee on Environment and Public Works to improve and strengthen the bill. S. 725, Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. S. 821, BPA in Food Packaging Right to Know Act The Breast Cancer Fund continues to meet with staff from Senate offices to encourage legislative action on the issue of bisphenol-A, which has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund support action that would ban bisphenol-A from the linings of canned food, foods marketed to children, and food storage containers. H.R.1735, National Defense Authorization Act for FY2016 (NDAA) The Breast Cancer Fund supports an amendment to NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Fund contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) The Breast Cancer Fund contacted Senate offices about preserving the current Design for the Environment program in the EPA. FUTURE LEGISLATIVE PROPOSALS: The Breast Cancer Fund visits Senate offices to support an amendment to the Senate NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). The Breast Cancer Fund supports this legislation to reform the FDAs regulation of cosmetic and personal care product ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Fund continues to talk with staff from Senate offices about the introduction of legislation in the Senate to reform the FDAs regulation of cosmetics and personal care product ingredients to prevent the use of chemicals found to have negative health and environmental impacts. REGULATION AND LEGISLATIVE INTENT: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Fund has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. P.L. 110-314 - The Consumer Product Safety Commission Improvement Act The Breast Cancer Fund lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation. Lobbying: U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Consumer Product Safety Commission (CPSC), National Institutes of Health (NIH), Environmental Protection Agency (EPA), Executive Office of the President (EOP), Office of Management & Budget (OMB), Health & Human Services - Department of (HHS), Office of Science & Technology Policy (OSTP), Health & Human Services - Dept of (HHS), Food & Drug Administration (FDA)

LEGISLATION IN THE 114TH CONGRESS​ S.1014, Personal Care Products Safety Act The Breast Cancer Fund continues to meet with staff from Senator Feinsteins office and other HELP committee offices to encourage legislative action on the issue of safety of Personal Care Products. The Breast Cancer Fund supports action that would remove toxins and regulate Personal Care Products and Cosmetics. H.R.2576, TSCA Modernization Act of 2015 The Breast Cancer Fund supports this bill and has been meeting with House and Senate offices to persuade members to take up the bill in the Senate. S. 697, Frank R. Lautenberg Chemical Safety for the 21st Century Act The Breast Cancer Fund opposes this legislation without amendments, as it would do little to strengthen the current TSCA law, but continues to work with members of the Senate Committee on Environment and Public Works to improve and strengthen the bill. S. 725, Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. S. 821, BPA in Food Packaging Right to Know Act The Breast Cancer Fund continues to meet with staff from Senate offices to encourage legislative action on the issue of bisphenol-A, which has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund support action that would ban bisphenol-A from the linings of canned food, foods marketed to children, and food storage containers. H.R.1735, National Defense Authorization Act for FY2016 (NDAA) The Breast Cancer Fund supports an amendment to NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Fund contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) The Breast Cancer Fund contacted Senate offices about preserving the current Design for the Environment program in the EPA. FUTURE LEGISLATIVE PROPOSALS: The Breast Cancer Fund visits Senate offices to support an amendment to the Senate NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). The Breast Cancer Fund supports this legislation to reform the FDAs regulation of cosmetic and personal care product ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Fund continues to talk with staff from Senate offices about the introduction of legislation in the Senate to reform the FDAs regulation of cosmetics and personal care product ingredients to prevent the use of chemicals found to have negative health and environmental impacts. REGULATION AND LEGISLATIVE INTENT: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Fund has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. P.L. 110-314 - The Consumer Product Safety Commission Improvement Act The Breast Cancer Fund lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation. Lobbying: U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Consumer Product Safety Commission (CPSC), National Institutes of Health (NIH), Environmental Protection Agency (EPA), Executive Office of the President (EOP), Office of Management & Budget (OMB), Health & Human Services - Department of (HHS), Office of Science & Technology Policy (OSTP), Health & Human Services - Dept of (HHS), Food & Drug Administration (FDA)

Bottled water labeling and quality; regulation of Bisphenol A in food and beverage containers, S. 821; FDA vending machine rules

Client expense: $130,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

Bottled water quality; regulation of Bisphenol A in food and beverage containers, S. 821

Client expense: $130,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

H.R. 185, Regulatory Accountability Act of 2015; H.R. 527; Small Business Regulatory Flexibility Improvements Act of 2015; H.R. 1029, EPA Science Advisory Board Reform Act of 2015; H.R. 1030, Secret Science Reform Act of 2015; H.R. 1321, Microbead-Free Waters Act of 2015; H.R. 2576; TSCA Modernization Act of 2015; H.R. 2577, Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2016; H.R. 2822, Department of the Interior, Environment, and Related Agencies Appropriations Act, 2016; H.R. 2995, Financial Services and General Government Appropriations Act, 2016; S. 543, EPA Science Advisory Board Reform Act of 2015; S. 544, Secret Science Reform Act of 2015; S. 697, Frank R. Lautenberg Chemical Safety for the 21st Century Act; S. 700, READ Act; S. 725, Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act; S. 821, BPA in Food Packaging Right to Know Act; S. 1014, Personal Care Products Safety Act; S. 1447, Sustainable Chemistry Research and Development Act of 2015; FY 2016 Appropriations of Department of Interior; FY 2016 Appropriations of Environmental Protection Agency; FY 2016 Appropriations Financial Services and General Government (Green Building Policies, Phthalates, CHAP and CPSC); FY 2016 Appropriations of Transportation, Housing and Urban Development, and Related Agencies; Good Science; A Bill to Provide for the Implementation of a Sustainable Chemistry Program, and for other Purposes; Bisphenol A; Chemical Safety Board; CPSC; CPSC Phthalates CHAP; Design for the Environment; Energy Recovery; Flame Retardants; Formaldehyde; Green Building Standards; Hexavalent Chromium; Integrated Risk Information System; Microbeads; Microplastics; Nanotechnology; OSHA Letters of Interpretation (Chemical Concentrations, Process Safety, RAGAGEP); Permitting Reform; Phthalates; Promoting New Manufacturing Act; Rare Earths; Risk Assessment Improvements; Report on Carcinogens; Science Advisory Board; SNUR; Styrene; T-TIP, MTB and Trade Promotion Authority; Toxic Substances Control Act (TSCA)(Including Confidential Business Information)

Health Insurance Coverage, Genetic Testing (general); Health Disparities (general); Emergency Contraception (general); Health Care Reform Implementation; Drug Dependence (general); HIV Screening (general); Gynecological Cancer; Breast Cancer (general); Breastfeeding (general); Medical Liability Reform (general); Health IT (general); Prematurity (general); Disparities (general); Prevention and Public Health Fund (general); Maternal Mortality (general); Imaging (general); Graduate Medical Education (general); Quality Improvement Measurement (general); Contraception (general); Postpartum Depression (general); CMS Provider Penalties (general); Preeclampsia (general); National Health Service Corps (general); Abortion (general); Indian Health (general); Teaching Health Centers (general); Research in Pregnant and Breastfeeding Women (general); H.R. 2866, Healthy MOM Act; CMS Health IT Incentive Program, Meaningful Use Stage 3; H.R. 1974, HEAL for Immigrant Women and Families Act of 2015; S. 466, Quality Care for Moms and Babies Act; S. 1427, Quality Measure Alignment Act of 2015; H.R. 836/S. 884, Health Care Safety Net Enhancement Act; H.R. 3658/S. 84, GEDI Act; H.R. 2603/S. 1475, Saving Lives, Saving Costs Act; Pregnancy Discrimination (general); S. 821, BPA in Food Packaging Right to Know Act; H.R. 1209/S.628 Improving Access to Maternity Care Act; H.R. 1462/S.799, Protecting our Infants Act; H.R. 6, 21st Century Cures Act; Innovation for Healthier Americans; Health Equity and Accountability Act; H.R. 293 Exempt certain transfers of value from reporting requirements under Sunshine Act; H.R. 1375/S. 142, Child Nicotine Poisoning Prevention Act; H.R. 3652/S. 674, 21st Century Womens Health Act; H.R.7/S. 582, No Taxpayer Funding for Abortion and Abortion Insurance Full Disclosure Act of 2015; H.R.36/S. 1553, Pain-Capable Unborn Child Protection Act; H.R. 448/S.217, Women's Health Protection Act of 2015; H.R. 865, Good Samaritan Health Professionals Act of 2015; H.R. 2654/S. 1512, Pregnant Workers Fairness Act; S. 1532, Affordability is Access Act; H.R. 2191/S. 1170, Breast Cancer Research Stamp Reauthorization Act of 2015; H.R. 1925, To award a Congressional Gold Medal to Dr. Ernie Bodai; H.R. 2058, FDA Deeming Authority Clarification Act of 2015; H.R. 3656/S. 2100, Tobacco to 21 Act; H.R. 3441, Accurate Education for Prenatal Screenings Act; H.R. 3339/S. 1926, Protecting Access to Lifesaving Screenings Act; H.R. 3235, Bringing Postpartum Depression Out of the Shadows Act; Shackling During Pregnancy (general); H.R. 3134/S. 764, Defund Planned Parenthood Act; H.R. 3504/S. 1603, Born-Alive Abortion Survivors Protection Act; H.R. 3495, Womens Public Health and Safety Act; H.R. 3539, Reinvigorating Antibiotic and Diagnostic Innovation; H.R. 3539, Reinvigorating Antibiotic and Diagnostic Innovation Act; H.R. 2407, School Milk Nutrition Act of 2015.

Bottled water quality, including proposals to ban bisphenol A, S. 821 "BPA in Food Packaging Right to Know Act"

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

LEGISLATION IN THE 114TH CONGRESS​ S.1014, Personal Care Products Safety Act The Breast Cancer Fund continues to meet with staff from Senator Feinsteins office and other HELP committee offices to encourage legislative action on the issue of safety of Personal Care Products. The Breast Cancer Fund supports action that would remove toxins and regulate Personal Care Products and Cosmetics. H.R.2576, TSCA Modernization Act of 2015 The Breast Cancer Fund supports this bill and has been meeting with House and Senate offices to persuade members to take up the bill in the Senate. S. 697, Frank R. Lautenberg Chemical Safety for the 21st Century Act The Breast Cancer Fund opposes this legislation without amendments, as it would do little to strengthen the current TSCA law, but continues to work with members of the Senate Committee on Environment and Public Works to improve and strengthen the bill. S. 725, Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. S. 821, BPA in Food Packaging Right to Know Act The Breast Cancer Fund continues to meet with staff from Senate offices to encourage legislative action on the issue of bisphenol-A, which has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund support action that would ban bisphenol-A from the linings of canned food, foods marketed to children, and food storage containers. H.R.1735, National Defense Authorization Act for FY2016 (NDAA) The Breast Cancer Fund supports an amendment to NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Fund contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) The Breast Cancer Fund contacted Senate offices about preserving the current Design for the Environment program in the EPA. FUTURE LEGISLATIVE PROPOSALS: The Breast Cancer Fund visits Senate offices to support an amendment to the Senate NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). The Breast Cancer Fund supports this legislation to reform the FDAs regulation of cosmetic and personal care product ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Fund continues to talk with staff from Senate offices about the introduction of legislation in the Senate to reform the FDAs regulation of cosmetics and personal care product ingredients to prevent the use of chemicals found to have negative health and environmental impacts. REGULATION AND LEGISLATIVE INTENT: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Fund has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. P.L. 110-314 - The Consumer Product Safety Commission Improvement Act The Breast Cancer Fund lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation. Lobbying: U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Consumer Product Safety Commission (CPSC), National Institutes of Health (NIH), Environmental Protection Agency (EPA), Executive Office of the President (EOP), Office of Management & Budget (OMB), Health & Human Services - Department of (HHS), Office of Science & Technology Policy (OSTP), Health & Human Services - Dept of (HHS), Food & Drug Administration (FDA)

H.R. 185, Regulatory Accountability Act of 2015; H.R. 527; Small Business Regulatory Flexibility Improvements Act of 2015; H.R. 1029, EPA Science Advisory Board Reform Act of 2015; H.R. 1030, Secret Science Reform Act of 2015; H.R. 1321, Microbead-Free Waters Act of 2015; H.R. 2576; TSCA Modernization Act of 2015; H.R. 2577, Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2016; H.R. 2822, Department of the Interior, Environment, and Related Agencies Appropriations Act, 2016; H.R. 2995, Financial Services and General Government Appropriations Act, 2016; S. 543, EPA Science Advisory Board Reform Act of 2015; S. 544, Secret Science Reform Act of 2015; S. 697, Frank R. Lautenberg Chemical Safety for the 21st Century Act; S. 700, READ Act; S. 725, Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act; S. 821, BPA in Food Packaging Right to Know Act; S. 1014, Personal Care Products Safety Act; S. 1447, Sustainable Chemistry Research and Development Act of 2015; A Bill to Provide for the Implementation of a Sustainable Chemistry Program, and for other Purposes; Bisphenol A; Chemical Safety Board; CPSC; CPSC Phthalates CHAP; Design for the Environment; Energy Recovery; Flame Retardants; Formaldehyde; FY 2016 Appropriations of Department of Interior; FY 2016 Appropriations Financial Services and General Government (Green Building Policies, Phthalates, CHAP and CPSC); FY 2016 Appropriations of Transportation, Housing and Urban Development, and Related Agencies; Good Science; Green Building Standards; Hexavalent Chromium; Integrated Risk Information System; Microbeads; Microplastics; Nanotechnology; Permitting Reform; Phthalates; Promoting New Manufacturing Act; Rare Earths; Report on Carcinogens; Science Advisory Board; SNUR; Styrene; T-TIP, MTB and Trade Promotion Authority; Toxic Substances Control Act (TSCA)(Including Confidential Business Information)

Health Insurance Coverage, Genetic Testing (general); Health Disparities (general); Emergency Contraception (general); Health Care Reform Implementation; Drug Dependence (general); HIV Screening (general); Gynecological Cancer; Breast Cancer (general); Breastfeeding (general); Medical Liability Reform (general); Health IT (general); Prematurity (general); Disparities (general); Prevention and Public Health Fund (general); Imaging (general); Graduate Medical Education (general); Quality Improvement Measurement (general); Contraception (general); CMS Provider Penalties (general); Preeclampsia (general); National Health Service Corps (general); Abortion (general); Indian Health (general); Teaching Health Centers (general); Special Enrollment Period for Pregnant Women; CMS Health IT incentive program, meaningful use State 3; Immigrant Health Care Access; S. 466, Quality Care for Moms and Babies Act; H.R. 836/S. 884, Health Care Safety Net Enhancement Act; Implementation of H.R. 3204, the Drug Quality and Security Act (113th); S. 84, GEDI Act; H.R.; H.R.919, CHIP Extension and Improvement Act of 2015; S.522, Protecting And Retaining Our Children's Health Insurance Program Act of 2015; Saving Lives, Saving Costs Act; Pregnancy Discrimination (general); S. 821, BPA in Food Packaging Right to Know Act; ; S.737, Ensuring Access to Primary Care for Women & Children Act; H.R. 1209/S.628 Improving Access to Maternity Care Act;; H.R. 1462/S.799, Protecting our Infants Act; 21st Century Cures; Innovation for Healthier Americans; Health Equity and Accountability Act; H.R. 5539 Except certain transfers of value from reporting requirements under Sunshine Act; H.R. 1375/S. 142, Child Nicotine Poisoning Prevention Act; S. 674, 21st Century Womens Health Act; S. 536, Indian Health Service Health Professions Tax Fairness Act; Training Tomorrows Doctors Today Act; H.R.7, No Taxpayer Funding for Abortion and Abortion Insurance Full Disclosure Act of 2015; H.R.36, Pain-Capable Unborn Child Protection Act; H.R. 448/S.217, Women's Health Protection Act of 2015; H.R. 865, Good Samaritan Health Professionals Act of 2015; H.R. 5524/S. 2687, Access to contraception for Women Service Members and Dependents Act; S 699, Frank R. Lautenberg Chemical Safety for the 21st Century Act

Bottled water quality; regulation of Bisphenol A in food and beverage containers, S. 821

Client expense: $100,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

Bottled water labeling and quality; regulation of Bisphenol A in food and beverage containers, S. 821; FDA vending machine rules

Client expense: $100,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

Bottled water quality, including proposals to ban bisphenol A, S. 821 "BPA in Food Packaging Right to Know Act"

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Legislation in the 114th S. 697, Frank R. Lautenberg Chemical Safety for the 21st Century Act The Breast Cancer Fund opposes this legislation in its current form, as it would do little to strengthen the current TSCA law, but continues to work with members of the Senate Committee on Environment and Public Works to improve and strengthen the bill. S. 725, Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. S. 821, BPA in Food Packaging Right to Know Act The Breast Cancer Fund continues to meet with staff from Senate offices to encourage legislative action on the issue of bisphenol-A, which has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund support action that would ban bisphenol-A from the linings of canned food, foods marketed to children, and food storage containers. House and Senate Appropriations The Breast Cancer Fund contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network National Institute of Environmental Health Sciences (NIEHS) H.R.1735, National Defense Authorization Act for FY2016 (NDAA) The Breast Cancer Fund supports an amendment to NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). Future Legislative Proposals: The Breast Cancer Fund visits Senate offices to support an amendment to the Senate NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). The Breast Cancer Fund supports this legislation to reform the FDAs regulation of cosmetic and personal care product ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Fund continues to talk with staff from Senate offices about the introduction of legislation in the Senate to reform the FDAs regulation of cosmetics and personal care product ingredients to prevent the use of chemicals found to have negative health and environmental impacts. Regulation and Legislative Intent: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Fund has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. P.L. 110-314 - The Consumer Product Safety Commission Improvement Act The Breast Cancer Fund lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation.

Bottled water labeling and quality; regulation of Bisphenol A in food and beverage containers, S. 821; FDA vending machine rules

Client expense: $90,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

Bottled water quality; regulation of Bisphenol A in food and beverage containers, S. 821

Client expense: $90,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

H.R. 185, Regulatory Accountability Act of 2015; H.R. 1029, EPA Science Advisory Board Reform Act of 2015; H.R. 1030, Secret Science Reform Act of 2015; H.R. 1321, Microbead-Free Waters Act of 2015; S. 543, EPA Science Advisory Board Reform Act of 2015; S. 544, Secret Science Reform Act of 2015; S. 697, Frank R. Lautenberg Chemical Safety for the 21st Century Act; S. 700, READ Act; S. 725, Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act; S. 821, BPA in Food Packaging Right to Know Act; A Bill to Provide for the Implementation of a Sustainable Chemistry Program, and for other Purposes; Bisphenol A; Chemical Safety Board; CPSC Phthalates CHAP; Design for the Environment; Energy Recovery; Flame Retardants; Formaldehyde; FY 2016 Appropriations of Department of Interior; FY 2016 Appropriations Financial Services and General Government (Green Building Policies, Phthalates, CHAP and CPSC); FY 2016 Appropriations of Transportation, Housing and Urban Development, and Related Agencies; Green Building Standards; Hexavalent Chromium; Integrated Risk Information System; Microbeads; Nanotechnology; Permitting Reform; Phthalates; Promoting New Manufacturing Act; Rare Earths; Science Advisory Board; SNUR; Styrene; T-TIP, MTB and Trade Promotion Authority; Toxic Substances Control Act (TSCA)(Including Confidential Business Information)

Client expense: $1,660,000 · Firm income: Not reported

Bottled water quality, including proposals to ban bisphenol A, S. 821 "BPA in Food Packaging Right to Know Act"

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Health Insurance Coverage, Genetic Testing (general); Health Disparities (general); Emergency Contraception (general); Health Care Reform Implementation; Drug Dependence (general); HIV Screening (general); Gynecological Cancer; Breast Cancer (general); Breastfeeding (general); Medical Liability Reform (general); Health IT (general); Prematurity (general); Disparities (general); Prevention and Public Health Fund (general); Imaging (general); Graduate Medical Education (general); Quality Improvement Measurement (general); Contraception (general); CMS Provider Penalties (general); Preeclampsia (general); National Health Service Corps (general); Abortion (general); Indian Health (general); Teaching Health Centers (general); Special Enrollment Period for Pregnant Women; CMS Health IT incentive program, meaningful use State 3; Immigrant Health Care Access; S. 466, Quality Care for Moms and Babies Act; H.R. 836/S. 884, Health Care Safety Net Enhancement Act; Implementation of H.R. 3204, the Drug Quality and Security Act (113th); S. 84, GEDI Act; H.R.; H.R.919, CHIP Extension and Improvement Act of 2015; S.522, Protecting And Retaining Our Children's Health Insurance Program Act of 2015; Saving Lives, Saving Costs Act; Pregnancy Discrimination (general); S. 821, BPA in Food Packaging Right to Know Act; ; S.737, Ensuring Access to Primary Care for Women & Children Act; H.R. 1209/S.628 Improving Access to Maternity Care Act;; H.R. 1462/S.799, Protecting our Infants Act; 21st Century Cures; Innovation for Healthier Americans; Health Equity and Accountability Act; H.R. 5539 Except certain transfers of value from reporting requirements under Sunshine Act; H.R. 1375/S. 142, Child Nicotine Poisoning Prevention Act; S. 674, 21st Century Womens Health Act; S. 536, Indian Health Service Health Professions Tax Fairness Act; Training Tomorrows Doctors Today Act; H.R.7, No Taxpayer Funding for Abortion and Abortion Insurance Full Disclosure Act of 2015; H.R.36, Pain-Capable Unborn Child Protection Act; H.R. 448/S.217, Women's Health Protection Act of 2015; H.R. 865, Good Samaritan Health Professionals Act of 2015; H.R. 5524/S. 2687, Access to contraception for Women Service Members and Dependents Act; S 699, Frank R. Lautenberg Chemical Safety for the 21st Century Act